Search Results

By Syed Ali Abutalib, MD, and Navneet Majhail, MD, MS, FASTCT  / July 10, 2024  / 2023 ASH

Chronic Graft-vs-Host Disease: Clinical Trial Updates

Chronic graft-vs-host disease, an immune-mediated disorder that follows allogeneic hematopoietic cell transplantation (allo-HCT), is characterized by debilitating tissue injury with inflammatory and fibrotic pathology leading to significant morbidity and mortality. Historically, the treatment of...